News Conference News ACC 2023 Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III Shelley Wood March 04, 2023
News Conference News EuroPCR 2022 Imaging in PCI for Patients at High Bleeding Risk: Data Point to Possibilities Caitlin E. Cox May 25, 2022
News Conference News TCT 2020 Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB Michael O'Riordan October 14, 2020
News Daily News Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show Michael O'Riordan October 17, 2018
News Conference News TCT 2018 Next Steps With NIRS: Lipid-Rich Plaque Study Shows Promise Identifying High-Risk Patients, Plaques Yael L. Maxwell September 24, 2018
News Conference News ACC 2017 CARAT: Novel HDL Mimetic Fails to Show Benefit in Coronary Atherosclerosis After ACS Yael L. Maxwell March 18, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Conference News AHA 2016 PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad Michael O'Riordan November 15, 2016
News Daily News MILANO-PILOT Falters, Effectively Ending the ApoA-1 Milano Saga Michael O'Riordan November 09, 2016
News Conference News TCT 2016 COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events Michael O'Riordan November 01, 2016
News Conference News TCT 2016 YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients Michael O'Riordan October 29, 2016
News Daily News Evolocumab Modifies IVUS-Detected Coronary Atherosclerosis: Topline Results From GLAGOV Michael O'Riordan September 20, 2016
News Daily News Statin Therapy Alters Composition of Coronary Plaques, Virtual Histology-IVUS Study Shows Michael O'Riordan April 14, 2016